Bill Bans Funds for Chinese Biotech Collaboration

Posted 1/26/24

Legislation barring federally-funded medical providers from signing contracts with foreign adversary biotech companies has been introduced in both the Senate and the house of Representatives.

The  Prohibiting Foreign Access to American Genetic Information Act of 2024 would ban all biotechnology companies that are owned or controlled by a foreign adversary, such as the Chinese Communist Party (CCP), and whose business practices threaten national security, from receiving U.S. taxpayer dollars through federal contracts, grants, and loans.

This item is available in full to subscribers.

Please log in to continue

Log in